Development of Recombinant Cell Line Co-expressing Mutated Nav1.5, Kir2.1, and hERG for the Safety Assay of Drug Candidates (Q39365157)
Jump to navigation
Jump to search
scientific article published on April 12, 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of Recombinant Cell Line Co-expressing Mutated Nav1.5, Kir2.1, and hERG for the Safety Assay of Drug Candidates |
scientific article published on April 12, 2012 |
Statements
1 reference
Development of recombinant cell line co-expressing mutated Nav1.5, Kir2.1, and hERG for the safety assay of drug candidates (English)
1 reference
Development of Recombinant Cell Line Co-expressing Mutated Nav1.5, Kir2.1, and hERG for the Safety Assay of Drug Candidates (English)
1 reference
Masato Fujii
1 reference
Susumu Ohya
1 reference
Hisao Yamamura
1 reference
Yuji Imaizumi
1 reference
12 April 2012
1 reference
1 reference
1 reference
1 reference
1 reference
17
1 reference
6
1 reference
773-784
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference